ATHIRA ATH-1017-AD-0203

Back to Drug Development Trials
Drug Development Trials

About the trial

Open-label extension of Studies ATH-1017-AD-0201 and ATH-1017-AD-0202 in subjects with mild to moderate Alzheimer’s disease.

View study